Docuraid logo
Documentation · Technical Writing

Docuraid

Docuraid is an AI writing assistant for hospital standard operating procedures. It searches existing documents, applies templates set by the quality department and drafts updates that a clinical specialist must validate, keeping every suggestion linked to its source.

Active Contact Sales No public API Verified by Guidaio
Overview

What is Docuraid?

Docuraid is an AI writing assistant built for one narrow job: drafting and updating the standard operating procedures and clinical procedures that hospitals run on. It is published by Hyperson BV, a Belgian data and AI consultancy based in Zaventem, and the footer describes the product plainly as "a Hyperson BV brand". The problem it targets is stated bluntly on the homepage: medical staff spend more time on paperwork than on patients, standards drift apart between departments, and clinicians fall back on general-purpose tools such as ChatGPT, which the vendor argues lack the guardrails and data privacy healthcare needs. The product answers with a three-step loop. First, Search: the tool works over existing procedures, external references and physicians' guidelines rather than from a blank page. Second, Select Template: the quality department defines the structure, so institutional consistency is imposed by design rather than left to each author. Third, Controlled Generation: a draft is produced from approved input only, and a clinical specialist validates the result. The vendor summarises this as human-in-the-loop with "100% Specialist Verification", and insists the final decision always sits with the physician. Three properties are claimed around that loop. Structured means templates drive institution-wide consistency. Explainable means each AI suggestion stays linked to the source data behind it. Traceable means version control, comprehensive logging and auditing of every change. The only customer named is UZ Leuven, the Leuven university hospital, credited with a claimed 40% time saving per procedure. Deployment is offered either as SaaS or on-premise, to fit hospital infrastructure. The vendor also announced a presence at HLTH Europe 2026 in Amsterdam. What is not there matters as much. The site is three pages long, in English and Dutch. There is no pricing, no free plan, no API, no mobile app, and no published terms, privacy policy or data processing agreement. Evaluation runs through a demo, then a pilot, then implementation.

What it does

  • Search across existing procedures, external references and physicians' guidelines
  • Apply a document template defined by the hospital quality department
  • Generate a procedure draft from approved input only
  • Route every draft to a clinical specialist for validation before it is used
  • Link each AI suggestion back to the source data it came from
  • Keep version control, change logs and a full audit trail of edits
  • Apply one institutional logic consistently across departments
Audience

When to use Docuraid / When not to

A quick filter to help you decide if Docuraid is the right fit.

When to use Docuraid

  • Hospital quality departments that own SOP templates and institutional document standards
  • Clinical specialists and physicians who spend hours rewriting and validating departmental procedures
  • Nurse managers and nurse educators maintaining unit protocols and training documents
  • Health information and clinical documentation managers facing inconsistent standards between departments
  • Hospital IT and compliance teams that need change logs, versioning and an on-premise option

When not to use Docuraid

  • Buyers who need a published price list: no rate is shown anywhere and access starts with a sales meeting
  • Teams looking for self-service sign-up or a free plan, neither of which the site offers
  • Organisations that require a public privacy policy, terms of service or DPA before evaluating a vendor
  • Developers expecting an API or integrations: no API surface, no documentation and no named connector exist
  • Clinicians looking for patient-facing documentation or medical scribing, which is not what this tool addresses
Get started

How to use Docuraid

A typical end-to-end flow, from setup to results.

  1. Request a demo from the website, which opens an online meeting booking with the vendor
  2. Alternatively, use the contact form or call the Belgian number listed on the About page
  3. Agree a focused pilot to validate Docuraid against your own hospital procedures
  4. Have the quality department define the document templates that will enforce institutional structure
  5. Choose the deployment model, either SaaS or on-premise, with your IT department
  6. Inside the tool, search existing procedures, external references and physicians' guidelines
  7. Select the approved template for the procedure you are writing or updating
  8. Let the assistant generate a draft from the approved input
  9. Review the draft as a clinical specialist and check each suggestion against its linked source
  10. Validate and publish, relying on the change log and version history for the audit trail
Quick read

Pros & Cons

Pros

  • Tightly scoped to hospital SOPs rather than sold as a general-purpose writing assistant
  • Human validation is presented as mandatory, with the final decision left to the physician
  • Traceability is a headline feature: logged interactions, source-linked suggestions, full version history
  • A named reference hospital, UZ Leuven, with a stated 40% time saving per procedure
  • On-premise deployment is offered alongside SaaS, which matters for hospital IT
  • The publisher is verifiable: Belgian company number, registered seat and a VAT number that validates
  • Consistency is enforced structurally through quality-department templates, not left to each author

Cons

  • No public pricing at all: no rate card, no plans, and no indication of order of magnitude
  • No terms of service, privacy policy or data processing agreement on either the product or publisher site
  • No named certification: compliance is claimed as a slogan, with no standard, number or certifying body
  • Nothing is published about where data is hosted, how long it is kept, or whether models train on it
  • No email address is published; contact runs through a form, a phone number or a meeting booking
  • A very thin site of three pages, with no public product documentation and no API
  • A young offering: the domain was registered in January 2026 and first archived in June 2026
Pricing

Pricing & Plans

No pricing is published. Docuraid displays no rate card, no plan and no amount of any kind, on either the product site or the publisher's site, and there is no pricing page to consult. There is no advertised free plan and no advertised free trial; a focused pilot is offered, but the site never states that it is free of charge. The commercial route is a sales one: a demo, then a pilot, then an implementation delivered either as SaaS or on-premise, with the cost settled by contract. Prospective buyers should expect the price to depend on deployment model and scope, and must request a quotation directly from the vendor.

Prices and plans listed above may evolve. Always check the official pricing page before subscribing.
Trust & Privacy

Data, GDPR & hosting

A consolidated view of how Docuraid handles your data.

GDPR overview

The publisher is established inside the European Union: Hyperson BV, Ikaroslaan 1, 1930 Zaventem, Belgium, registered with the Belgian Crossroads Bank for Enterprises under number 1023.186.088 and holding a VAT number that validates against VIES. Beyond that, there are no concrete GDPR mentions to report. The site publishes no privacy policy, no terms, no data processing agreement, no subprocessor list, no data protection officer and no retention rules, and the same is true of the publisher's own website. The only related wording is marketing: generic AI tools are said to lack "the guardrails and data privacy needed for healthcare". The tool never claims GDPR compliance and never denies it, so the compliance field is left empty rather than answered. An EU Article 27 representative is not required here, the controller being EU-based.

Who owns the data?

Docuraid publishes no terms and conditions, so data ownership is not contractually defined anywhere we could find. Neither docuraid.com nor the publisher's own site, hyperson.ai, carries terms, a privacy policy or a data processing agreement, and their absence was confirmed by three independent page enumerations. What the site does state is operational rather than legal: the AI drafts from approved input, the clinical specialist validates the output, and the final decision belongs to the physician. Nothing describes who owns the source procedures, the generated drafts or the audit logs. Prospective hospitals should therefore expect ownership, licensing and reuse terms to be settled in the contract negotiated during the pilot, not read from a public document.

Reuse rights

No published terms grant or restrict reuse of the material, because no terms are published at all. The site describes the workflow instead: procedures are generated from approved input such as existing documents, external references and physicians' guidelines, every AI interaction is logged, and every generation is referenced back to its source data. In practice the customer works on its own institutional content, and the output is a hospital procedure that the institution validates and then applies. Whether the customer may reuse, export or redistribute that output without asking, and whether the vendor may use customer material for any purpose of its own, is not addressed publicly. Nothing on either site mentions model training, opt-out or retention. These points have to be raised directly with the vendor.

Data retention & training

Retention summary
No retention rules are published. There is no privacy policy and no terms of service on either the product or the publisher site, and no statement anywhere about how long data is kept, whether it is anonymised, or how deletion is requested or performed. The closest related feature is documentary rather than legal: the vendor advertises version control with comprehensive logging and auditing of all changes, which by design implies that previous versions of procedures and a history of edits are retained. That is presented as a governance capability for the customer, not as a retention policy, and it says nothing about the vendor's own handling of the data. Retention, deletion and archiving terms have to be requested from the vendor.

Hosting summary

Nothing is published about data hosting. Neither the product site nor the publisher's site names a hosting country, a region, a cloud provider or a jurisdiction, and there is no privacy policy, security page or trust centre where such information would normally sit. The only infrastructure statement is about the deployment model: implementation can be done via SaaS or on-premise to fit the hospital's infrastructure needs. The on-premise option is significant, since it would place data inside the hospital's own estate and under its own jurisdiction, but the site gives no detail on what it covers. For the SaaS option, no location is stated at all. The publisher is established in Belgium, which places the controller inside the European Union, but company residence is not a hosting commitment. Any hospital assessing this tool should obtain the hosting location, the jurisdiction and the subprocessor list in writing before a pilot.

Watch-outs

Things to keep in mind

Risks and trade-offs to weigh before adopting Docuraid.

  • No terms, privacy policy or DPA are published: nothing about data handling is contractually verifiable before you sign
  • Automation bias is the core clinical risk: validation is only meaningful if specialists genuinely read drafts rather than approve them
  • Faster procedure output can quietly become more procedures than a department can actually review and keep current
  • The registered company date belongs to Hyperson BV, the consultancy, not to Docuraid, whose domain dates from January 2026
  • "Fully compliant" and "built-in compliance" are marketing phrases here, with no standard, certificate number or auditor named
  • The 40% time saving and the single hospital reference are vendor claims with no published methodology
  • Relying on generated procedures may erode the institutional habit of writing and debating protocols in-house
Setup

Setup & Integrations

Technical difficulty

There is no self-service option, so the effort is organisational before it is technical. Onboarding runs through a demo, a focused pilot and then an implementation. The SaaS route should be light for the customer; the on-premise route implies involving hospital IT. The real prerequisite is on the business side: the quality department has to define the document templates that give the tool its structure, and clinical specialists must be available to validate outputs. No public technical documentation, API or named connector exists, so integration questions have to be settled directly with the vendor.

Deployment

Web app
Company

Behind Docuraid

Company name
Hyperson BV
Founded
09/05/2025
Country of origin
🇧🇪 Belgium
Headquarters
Ikaroslaan 1, 1930 Zaventem, Belgium
UBO
INFORMATION_NOT_FOUND
UBO country
INFORMATION_NOT_FOUND
Domain registrar country
🇺🇸 United States

Social

Official links

Resources

All the official URLs gathered for verification and reference.

Compare

Alternatives

Tools that compete with or complement Docuraid.

C ChatGPT
FAQ

Frequently asked questions

What does Docuraid actually do?
It is an AI writing assistant for hospital standard operating procedures. It searches existing procedures, external references and physicians' guidelines, applies a template defined by the quality department, and generates a draft that a clinical specialist then validates.
Who is behind Docuraid?
Hyperson BV, a data and AI consultancy based at Ikaroslaan 1, 1930 Zaventem, Belgium, registered under enterprise number 1023.186.088. The site describes Docuraid as a Hyperson BV brand.
Does the AI write procedures on its own?
No. The vendor describes a human-in-the-loop process: the quality department sets the template, generation uses approved input only, a clinical specialist validates the output, and the final decision is stated to rest with the physician.
How is traceability handled?
The vendor states that every AI interaction is logged, every generation is referenced back to its source data, and all changes are kept under version control with comprehensive logging and auditing.
How much does Docuraid cost?
No price is published. There is no pricing page and no amount appears anywhere on the site. Access starts with a demo, followed by a pilot and then an implementation priced by contract.
Can it be hosted on our own infrastructure?
The site states that implementation can be done via SaaS or on-premise to fit the hospital's infrastructure needs. No hosting country or region is named for the SaaS option.
Is there an API or a mobile app?
Neither was found. No API documentation, endpoint or developer subdomain exists, and no iOS or Android application could be located in either app store.
What are the GDPR guarantees?
The publisher is established in Belgium, inside the European Union, but the site publishes no privacy policy, no terms, no data processing agreement and no subprocessor list. These points have to be raised with the vendor directly.
What results does the vendor claim?
A 40% time saving per procedure, attributed to UZ Leuven, the only customer named on the site. No methodology is published to support the figure.
How do I get in touch?
Through the contact form on the site, the Belgian phone number published on the About page, or the online meeting booking behind the Request Demo button. No email address is published.
Conclusion

Should you pick Docuraid?

Docuraid is a narrow, credible answer to a real hospital problem. Writing and refreshing standard operating procedures is slow, inconsistent between departments, and increasingly done with general-purpose chatbots that were never designed for clinical governance. The product's structure addresses exactly that: templates owned by the quality department, generation restricted to approved input, mandatory validation by a clinical specialist, and an audit trail linking every suggestion back to its source. Offering on-premise deployment alongside SaaS shows the vendor understands who it is selling to. The reservations are about transparency rather than intent. There is no published price of any kind, so the budget conversation only begins after a sales meeting. More importantly for a healthcare buyer, there is no privacy policy, no terms of service and no data processing agreement on either the product site or the publisher's own site, and no named certification: "compliance" appears as a slogan, never as a standard with a number and a certifying body. Nothing is said about where data is hosted, how long it is kept, or whether models are trained on customer content. The single customer reference and the 40% figure are vendor claims without published methodology. It is also an early-stage offering. The publisher, Hyperson BV, is a Belgian consultancy incorporated in May 2025; the Docuraid domain was registered in January 2026 and first archived in June 2026. That is not a fault, but it does mean the product is being evaluated on a promise more than a track record. For a hospital quality department, the sensible path is the one the vendor proposes: take the demo, run the pilot, and use the contract to obtain in writing the data, retention and security commitments the website does not provide.